vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and loanDepot, Inc. (LDI). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $310.3M, roughly 1.2× loanDepot, Inc.). AdvanSix Inc. runs the higher net margin — -0.8% vs -7.2%, a 6.5% gap on every dollar of revenue. On growth, loanDepot, Inc. posted the faster year-over-year revenue change (20.5% vs 9.4%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $-648.0M). Over the past eight quarters, loanDepot, Inc.'s revenue compounded faster (18.0% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
LoanDepot, sometimes stylized as loanDepot, is an Irvine, California-based nonbank holding company which sells mortgage and non-mortgage lending products.
ASIX vs LDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $310.3M |
| Net Profit | $-2.8M | $-22.5M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | -10.3% |
| Net Margin | -0.8% | -7.2% |
| Revenue YoY | 9.4% | 20.5% |
| Net Profit YoY | -892.9% | 32.4% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $310.3M | ||
| Q3 25 | $374.5M | $323.3M | ||
| Q2 25 | $410.0M | $282.5M | ||
| Q1 25 | $377.8M | $273.6M | ||
| Q4 24 | $329.1M | $257.5M | ||
| Q3 24 | $398.2M | $314.6M | ||
| Q2 24 | $453.5M | $265.4M | ||
| Q1 24 | $336.8M | $222.8M |
| Q4 25 | $-2.8M | $-22.5M | ||
| Q3 25 | $-2.6M | $-4.9M | ||
| Q2 25 | $31.4M | $-13.4M | ||
| Q1 25 | $23.3M | $-21.9M | ||
| Q4 24 | $352.0K | $-33.2M | ||
| Q3 24 | $22.3M | $1.4M | ||
| Q2 24 | $38.9M | $-32.2M | ||
| Q1 24 | $-17.4M | $-34.3M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | -10.3% | ||
| Q3 25 | -0.9% | -3.2% | ||
| Q2 25 | 7.7% | -11.4% | ||
| Q1 25 | 7.7% | -16.8% | ||
| Q4 24 | -3.9% | -32.7% | ||
| Q3 24 | 7.5% | 1.1% | ||
| Q2 24 | 11.5% | -29.1% | ||
| Q1 24 | -7.0% | -38.2% |
| Q4 25 | -0.8% | -7.2% | ||
| Q3 25 | -0.7% | -1.5% | ||
| Q2 25 | 7.7% | -4.7% | ||
| Q1 25 | 6.2% | -8.0% | ||
| Q4 24 | 0.1% | -12.9% | ||
| Q3 24 | 5.6% | 0.4% | ||
| Q2 24 | 8.6% | -12.1% | ||
| Q1 24 | -5.2% | -15.4% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $1.15 | — | ||
| Q1 25 | $0.86 | — | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.82 | $0.01 | ||
| Q2 24 | $1.43 | $-0.18 | ||
| Q1 24 | $-0.65 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $337.2M |
| Total DebtLower is stronger | — | $2.1B |
| Stockholders' EquityBook value | $815.2M | $386.0M |
| Total Assets | $1.7B | $6.9B |
| Debt / EquityLower = less leverage | — | 5.44× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $337.2M | ||
| Q3 25 | $23.7M | $459.2M | ||
| Q2 25 | $18.4M | $408.6M | ||
| Q1 25 | $8.3M | $371.5M | ||
| Q4 24 | $19.6M | $421.6M | ||
| Q3 24 | $17.3M | $483.0M | ||
| Q2 24 | $12.1M | $533.2M | ||
| Q1 24 | $20.6M | $603.7M |
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.3B |
| Q4 25 | $815.2M | $386.0M | ||
| Q3 25 | $818.2M | $433.3M | ||
| Q2 25 | $823.7M | $439.1M | ||
| Q1 25 | $794.4M | $469.3M | ||
| Q4 24 | $774.6M | $506.6M | ||
| Q3 24 | $766.4M | $592.0M | ||
| Q2 24 | $746.6M | $578.9M | ||
| Q1 24 | $713.2M | $637.3M |
| Q4 25 | $1.7B | $6.9B | ||
| Q3 25 | $1.7B | $6.2B | ||
| Q2 25 | $1.6B | $6.2B | ||
| Q1 25 | $1.6B | $6.4B | ||
| Q4 24 | $1.6B | $6.3B | ||
| Q3 24 | $1.5B | $6.4B | ||
| Q2 24 | $1.5B | $5.9B | ||
| Q1 24 | $1.5B | $6.2B |
| Q4 25 | — | 5.44× | ||
| Q3 25 | — | 4.83× | ||
| Q2 25 | — | 4.70× | ||
| Q1 25 | — | 4.30× | ||
| Q4 24 | — | 4.00× | ||
| Q3 24 | — | 3.31× | ||
| Q2 24 | — | 3.41× | ||
| Q1 24 | — | 3.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $-638.7M |
| Free Cash FlowOCF − Capex | $36.1M | $-648.0M |
| FCF MarginFCF / Revenue | 10.0% | -208.9% |
| Capex IntensityCapex / Revenue | 7.7% | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $-734.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $-638.7M | ||
| Q3 25 | $26.6M | $43.4M | ||
| Q2 25 | $21.1M | $67.6M | ||
| Q1 25 | $11.4M | $-179.9M | ||
| Q4 24 | $64.2M | $47.7M | ||
| Q3 24 | $57.3M | $-349.2M | ||
| Q2 24 | $50.2M | $-278.3M | ||
| Q1 24 | $-36.2M | $-278.5M |
| Q4 25 | $36.1M | $-648.0M | ||
| Q3 25 | $66.0K | $38.7M | ||
| Q2 25 | $-7.2M | $61.4M | ||
| Q1 25 | $-22.6M | $-186.7M | ||
| Q4 24 | $29.8M | $40.8M | ||
| Q3 24 | $26.8M | $-356.4M | ||
| Q2 24 | $16.7M | $-285.7M | ||
| Q1 24 | $-71.6M | $-283.3M |
| Q4 25 | 10.0% | -208.9% | ||
| Q3 25 | 0.0% | 12.0% | ||
| Q2 25 | -1.7% | 21.7% | ||
| Q1 25 | -6.0% | -68.2% | ||
| Q4 24 | 9.1% | 15.8% | ||
| Q3 24 | 6.7% | -113.3% | ||
| Q2 24 | 3.7% | -107.7% | ||
| Q1 24 | -21.3% | -127.2% |
| Q4 25 | 7.7% | 3.0% | ||
| Q3 25 | 7.1% | 1.5% | ||
| Q2 25 | 6.9% | 2.2% | ||
| Q1 25 | 9.0% | 2.5% | ||
| Q4 24 | 10.4% | 2.7% | ||
| Q3 24 | 7.7% | 2.3% | ||
| Q2 24 | 7.4% | 2.8% | ||
| Q1 24 | 10.5% | 2.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | -255.05× | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
LDI
Segment breakdown not available.
